PMID- 37718297
OWN - NLM
STAT- MEDLINE
DCOM- 20230919
LR  - 20231223
IS  - 1833-3516 (Print)
IS  - 2209-1491 (Electronic)
IS  - 1833-3516 (Linking)
VI  - 53
IP  - 3
DP  - 2023 Sep 30
TI  - Contemporary practices of blood glucose management in diabetic patients: a survey 
      of hyperbaric medicine units in Australia and New Zealand.
PG  - 230-236
LID - 10.28920/dhm53.3.230-236 [doi]
AB  - INTRODUCTION: Blood glucose levels may be influenced by hyperbaric oxygen 
      treatment (HBOT). Patients with diabetes mellitus commonly receive HBOT but there 
      is a lack of standardised blood glucose management guidelines. We documented 
      relevant contemporary practices applied for patients with diabetes treated in 
      hyperbaric medicine units. METHODS: A survey was administered in 2022 to the 
      directors of all 13 accredited hyperbaric units in Australia and New Zealand to 
      identify policies and practices related to management of patients with diabetes 
      receiving HBOT. RESULTS: Twelve of the 13 units routinely managed patients with 
      diabetes. Three-quarters (9/12) used < 4 mmol.l(-1) as their definition of 
      hypoglycaemia, whereas the other three used < 5, < 3.6, and < 3 mmol.l(-1). Units 
      reported 26% (range 13-66%) of their patients have a diagnosis of diabetes of 
      which 93% are type 2. Ten (83%) units reported specific written protocols for 
      managing blood glucose. Protocols were more likely to be followed by nursing 
      (73%) than medical staff (45%). Ten (83%) units routinely tested blood glucose 
      levels on all patients with diabetes. Preferred pre-treatment values for 
      treatments in both multiplace and monoplace chambers ranged from >/= 4 to >/= 8 
      mmol.l(-1). Seven (58%) units reported continuation of routine testing throughout 
      a treatment course with five (42%) units having criteria-based rules for 
      discontinuing testing for stable patients over multiple treatments. Two-thirds of 
      units were satisfied with their current policy. CONCLUSIONS: This survey 
      highlights the burden of diabetes on patients treated with HBOT and identifies 
      considerable variability in practices which may benefit from further study to 
      optimise management of these patients.
CI  - Copyright: This article is the copyright of the authors who grant Diving and 
      Hyperbaric Medicine a non-exclusive licence to publish the article in electronic 
      and other forms.
FAU - Laupland, Brenda R
AU  - Laupland BR
AD  - Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Brisbane, 
      Australia.
AD  - Corresponding author: Dr Brenda Laupland, Hyperbaric Medicine Unit, Royal 
      Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, 4029 
      Australia, ORCiD ID: 0009-0005-4883-1932, kbetlaup@gmail.com.
FAU - Laupland, Kevin
AU  - Laupland K
AD  - Queensland University of Technology (QUT), Brisbane, Australia.
AD  - Department of Intensive Care Services, Royal Brisbane and Women's Hospital, 
      Brisbane, Australia.
FAU - Thistlethwaite, Kenneth
AU  - Thistlethwaite K
AD  - Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Brisbane, 
      Australia.
FAU - Webb, Robert
AU  - Webb R
AD  - Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Brisbane, 
      Australia.
AD  - Clinical Informatics, Digital Metro North, Metro North Health, Brisbane, 
      Australia.
LA  - eng
PT  - Journal Article
PL  - Australia
TA  - Diving Hyperb Med
JT  - Diving and hyperbaric medicine
JID - 101282742
RN  - 0 (Blood Glucose)
RN  - S88TT14065 (Oxygen)
SB  - IM
MH  - Humans
MH  - *Hyperbaric Oxygenation
MH  - Blood Glucose
MH  - New Zealand
MH  - *Diabetes Mellitus/therapy
MH  - Australia
MH  - Oxygen
PMC - PMC10735644
OTO - NOTNLM
OT  - Blood sugar level
OT  - Diabetes
OT  - Hyperbaric oxygen treatment
OT  - Protocol
OT  - Questionnaire
COIS- Conflict of interest and funding: nil
EDAT- 2023/09/18 00:41
MHDA- 2023/09/19 06:42
PMCR- 2024/09/30
CRDT- 2023/09/17 22:53
PHST- 2023/03/30 00:00 [received]
PHST- 2023/07/25 00:00 [accepted]
PHST- 2024/09/30 00:00 [pmc-release]
PHST- 2023/09/19 06:42 [medline]
PHST- 2023/09/18 00:41 [pubmed]
PHST- 2023/09/17 22:53 [entrez]
AID - 10.28920/dhm53.3.230-236 [doi]
PST - ppublish
SO  - Diving Hyperb Med. 2023 Sep 30;53(3):230-236. doi: 10.28920/dhm53.3.230-236.